Form D · Investing
Brooklyn Immunotherapeutics Investors LP
Houston, TX · CIK 0001758682
Offering snapshot reported Nov 19, 2018 · SEC filing
- Reported sold
- $21.2M Offering amount: $21.2M
- Investors reported
- 85 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 6, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 19, 2018 | Initial | $21,180,153 | No comparison | 85 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b, 3C, 3C.1
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-326067
Source: Form D, filed Nov 19, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| N/A Brooklyn Immunotherapeutics Investors Gp Llc | Director |
| Charles R. Cherington | Director |
| George P. Denny Iii | Director |
Issuer details
Industry: Investing (See others in industry)
Address:
109 N. Post Oak Lane, Suite 530
Houston, TX, 77024
Houston, TX, 77024